Clinical Trials
3
Trial Phases
2 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2025-05-22
- Lead Sponsor
- Abion Inc
- Target Recruit Count
- 178
- Registration Number
- NCT05541822
- Locations
- 🇺🇸
Cancer Care of North Florida, PA (Lake City Cancer Care, LLC) - Medical Oncology, Lake City, Florida, United States
🇺🇸Mid Florida Center, Orange City, Florida, United States
🇺🇸The Henry Ford Cancer Institute, Detroit, Michigan, United States
To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers
- Conditions
- Solid Tumor
- Interventions
- Other: High-fat meal (over 900 kcal)Drug: ABN401 (investigational product)
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2024-02-20
- Lead Sponsor
- Abion Inc
- Target Recruit Count
- 25
- Registration Number
- NCT05248074
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Seowon-gu, Korea, Republic of
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation
- Conditions
- Advanced Solid Tumors
- Interventions
- Drug: ABN401- Escalation PhaseDrug: ABN401- Expansion Phase
- First Posted Date
- 2019-08-12
- Last Posted Date
- 2025-01-06
- Lead Sponsor
- Abion Inc
- Target Recruit Count
- 24
- Registration Number
- NCT04052971
- Locations
- 🇦🇺
ST George Private Hospital, Kogarah, New South Wales, Australia
🇦🇺Sydney Southwest Private Hospital, Liverpool, New South Wales, Australia
🇦🇺Scientia Clinical Research, Randwick, New South Wales, Australia